Center for Global Health Policy’s “Science Speaks”: “A sweetheart deal” “deplorable” “immoral and unacceptable” “Massive victory for big pharma” … We’re reading about TPP’s pharma rules, and an update on a 5000-percent price hike
Antigone Barton, senior writer and editor of “Science Speaks,” discusses a leaked version of the Trans-Pacific Partnership trade agreement’s pharmaceutical provision, as well as reaction to the leaked chapter. She also writes about some of the consequences of the recent 5,000 percent price increase on Turing Pharmaceuticals’ Daraprim, a treatment for toxoplasmosis (10/20).